Hyundai reaffirms 25,000 Atlas robots — 83% for its own plants — days after settling a strike over automation.

At Hyundai Motor's 2026 CEO Investor Day in Seoul on August 26, president and CEO José Muñoz gave the most concrete public accounting yet of what the automaker intends to do with Boston Dynamics' Atlas humanoid, which became a wholly owned Hyundai subsidiary in June after a $325 million buyout of SoftBank's remaining stake. Hyundai will build a US robotics manufacturing facility that starts production in 2028 at 30,000 units of annual capacity — which Muñoz called 'the world's first large-scale commercial robotics manufacturing facility,' a superlative worth holding lightly given that Tesla, Figure and several Chinese makers have claimed versions of the same. More revealing than the capacity was the demand behind it: 'The first 25,000 commercial units are already confirmed,' Muñoz said, 'starting with the Metaplant, and we are utilizing additional industrial and logistics partners.' That is roughly 83% of the plant's first-year output — and it points inward. Hyundai is, for now, overwhelmingly its own customer. The figures were first floated at a JPMorgan investor session in May; this restated them from the CEO's own stage.

What made the presentation notable was the calendar around it. Roughly forty minutes into the roadmap of vehicle launches and margin targets, Muñoz paused to insist that 'robots are in service of humans' and, more pointedly, that 'robots are not replacing humans — we are creating new categories of jobs like robot maintenance.' He delivered that line one day after Hyundai's South Korean union reached a tentative agreement ending its first full strike in a decade, a walkout begun on August 21 in which protection against artificial intelligence and automation was an explicit demand. On that specific issue the settlement is thin: as reviewed by Reuters, the two sides agreed only to 'discuss matters related to employment when it comes to rolling out new businesses' — a commitment to a conversation, not a veto over humanoid deployment. And the deal was not yet final: it faced a member ratification vote on Monday, August 31, which means the investor day landed squarely inside the ratification window and made the 'not replacing humans' passage read less like boilerplate than like a message aimed at a particular audience.

Strip away the framing and the operational picture is a captive rollout on a distant timeline. Atlas is slated to arrive at scale at Hyundai Motor Group Metaplant America in Georgia in 2028, beginning with parts-sequencing work and expanding toward component assembly by 2030, with broader global deployment from 2030. Feeding that is the Robot Metaplant Application Center, which opened in the US in June and will expand 'more than ten-fold' by year's end; it is where Atlas is currently being validated against real factory conditions, running parts sequencing across five vehicles and 67 items before it ever touches a live line. Muñoz also floated a commercial channel that does not yet exist, saying Hyundai has 'potential distribution for selling robots through our dealer partners' and that Hyundai Capital 'is exploring the feasibility to finance sales of robots.' Both were explicitly hedged — no dealer named, no robot priced, no timeline given — and function as a vertical-integration pitch to investors ('development, production, distribution, sales, finance — this is the power of the Group') rather than a product you can order.

For an industrial buyer, the message this week is the same as it was in July, only sharper: Atlas is not for sale to you. With about 83% of first-year output committed to Hyundai's own factories and the remainder going to unnamed 'industrial and logistics partners,' the plant is building a captive fleet, not an order book outsiders can join, and the dealer-sales and financing ideas are trial balloons rather than channels. If your timeline is near-term, the humanoids taking outside orders now — Agility's Digit at GXO, Figure's units at BMW, Apptronik's Apollo at Mercedes — remain the shortlist; Atlas is a 2028-to-2030 bet on Hyundai's own manufacturing calendar. The labor friction is itself a buyer signal. Even the maker that owns its plants and its robot outright is negotiating hard with its workforce over how and where the machines get deployed, a reminder that humanoid rollouts carry organizational costs — union agreements, job redefinition, retraining — that never appear on a spec sheet and that any large employer should budget for before the first unit arrives.